Euglena Co., Ltd. (TYO:2931)

Market Cap	57.65B -19.3%
Revenue (ttm)	50.37B +5.8%
Net Income	-805.00M
EPS	-5.90
Shares Out	139.25M
PE Ratio	n/a
Forward PE	147.86
Dividend	2.00 (0.50%)
Ex-Dividend Date	Dec 29, 2025

Volume	959,800
Average Volume	1,364,250
Open	416.00
Previous Close	414.00
Day's Range	412.00 - 419.00
52-Week Range	356.00 - 513.00
Beta	-0.13
RSI	60.59
Earnings Date	May 14, 2026

About Euglena

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and socia...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2005
• Employees: 793
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2931

Financial Performance

In 2025, Euglena's revenue was 50.37 billion, an increase of 5.78% compared to the previous year's 47.62 billion. Losses were -805.00 million, 23.8% more than in 2024.